Beckman Coulter Biomedical Division recalls
Beckman Coulter Biomedical Division has 1 recall on record with the FDA and USDA, the earliest in 2023 and the latest reported on 22 Nov 2023. 1 is still ongoing. The most frequent reason is potency & assay.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing1latest 22 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why beckman coulter biomedical division is recalled
Product types
By year
Ongoing beckman coulter biomedical division recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | AU/DxC AU Chemistry Transferrin recalled by Beckman Coulter Biomedical | Beckman Coulter Biomedical Division | Potency & Assay | Nationwide |
All beckman coulter biomedical division recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | AU/DxC AU Chemistry Transferrin recalled by Beckman Coulter Biomedical | Beckman Coulter Biomedical Division | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.